the objectives of this open-labeled , multiple-dose , three-way-crossover trial were to evaluate the safety and tolerance of zidovudine ( retrovir ) oral syrup and to assess the bioequivalence of this formulation relative to zidovudine solution and capsule formulations in human immunodeficiency virus-infected patients .
C0699576
retrovir
C0043474
zidovudine